|
|
|
| Professor Song Aiyin’s experience in treating recurrent laryngeal nerve paralysis after lung cancer surgery based on syndrome differentiation |
| KONG Youqian1 SONG Aiying2▲#br# |
1.Graduate School, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.Department of Oncology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China |
|
|
|
Abstract Recurrent laryngeal nerve paralysis is a common complication after lung cancer surgery. The pathogenesis is complex and its condition is difficult to heal, which seriously affects the quality of life of patients. Professor Song Aiying is a famous traditional Chinese medicine in Heilongjiang Province. She has rich clinical experience in the diagnosis and treatment of recurrent laryngeal nerve paralysis after lung cancer surgery. According to Professor Song Aiying, the disease pathogenesis is incised wound, laryngeal pulse damage, which leads to qi deficiency and blood stasis, and loss of maintenance for laryngeal orifices. Therefore, the treatment method of supplementing qi and dispersing blood stasis, reinforcement and elimination in combination is put forward. The self-made Tongluo Kaiyin Decoction has good clinical effect. The author followed Professor Song Aiying, summarizes her clinical diagnosis and treatment ideas, summarizes and shares Professor Song Aiying’s traditional Chinese medicine syndrome differentiation ideas and treatment experience of recurrent laryngeal nerve paralysis after lung cancer surgery, and analyzes two experimental cases.
|
|
|
|
|
|
[1] Sano Y，Shigematsu H，Okazaki M，et al. Hoarseness after radical surgery with systematic lymph node dissection for primary lung cancer [J]. Eur J Cardiothorac Surg，2019，55（2）：280-285.
[2] Laccourreye O，Malinvaud D，Delas B，et al. Early unilateral laryngeal paralysis after pulmonary resection with mediastinal dissection for cancer [J]. Ann Thorac Surg，2010，90（4）：1075-1078.
[3] Cocuzza S，Di Luca M，Maniaci A，et al. Precision treatment of post pneumonectomy unilateral laryngeal paralysis due to cancer [J]. Future Oncol，2020，16（16s）：45-53.
[4] Li H，Hu Y，Huang J，et al. Attempt of peripheral nerve reconstruction during lung cancer surgery [J]. Thorac Cancer，2018，9（5）：580-583.
[5] 段淑文，王小荣，姚蕙莹，等.《东医宝鉴》中失音的辨治规律浅析[J].中国中医基础医学杂志，2021，27（5）：723-725.
[6] 马俊男，柳成刚.喉瘖源流考[J].中国中医急症，2020，29（9）：1658-1660，1673.
[7] 李密密，马金成，宗凯，等.从《黄帝内经》“一阴一阳结谓之喉痹”治疗喉咳新探[J].环球中医药，2020，13（8）：1371-1373.
[8] 罗芳.“一阴一阳结，谓之喉痹”之探讨[J].四川中医，2011，29（11）：46-47.
[9] 张逸雯.中医学“结”的理论与应用研究[D].北京：中国中医科学院，2020.
[10] 原发性肺癌诊疗规范（2018年版）[J].肿瘤综合治疗电子杂志，2019，5（3）：100-120.
[11] 刘丹，王允，王子豪.用中医思维理解肺癌根治术患者围手术期的病理生理学状态[J].四川中医，2018，36（2）：34-38.
[12] Nakamura Y，Shindo Y，Arai W，et al. Two cases of left recurrent laryngeal nerve paralysis after right superior mediastinal node dissection [J]. Surg Case Rep，2021，7（1）：151.
[13] 赵振军，陈荣军.甲状腺手术并发喉返神经损伤的临床原因探究[J].吉林医药学院学报，2020，41（1）：38-40.
[14] Gelpke H，Grieder F，Decurtins M，et al. Recurrent laryngeal nerve monitoring during esophagectomy and mediastinal lymph node dissection [J]. World J Surg，2010，34（10）：2379-2382.
[15] 肖水芳.规范喉神经损伤的功能评估与治疗[J].中国耳鼻咽喉颅底外科杂志，2020，26（4）：355-359.
[16] 许炜茹，林洪生.林洪生教授治疗肺癌经验总结[J].中国医药导报，2019，16（9）：131-133.
[17] 刘殿龙，陈雨，崔述生，等.补脾调气法在非小细胞肺癌治疗中的应用[J].中国医药导报，2019，16（33）：133-136.
[18] 何佩珊，杨公博，潘国凤，等.老年非小细胞肺癌患者围手术期证型变化及防治策略[J].中华中医药杂志，2017， 32（3）：1057-1059.
[19] 权浩浩，张晓凤，高凯，等.基于网络药理学的僵蚕主要药效作用研究[J].西部中医药，2021，34（3）：92-96.
[20] 姚超，徐艺.单兆伟教授临证运用“木蝴蝶”的经验[J].中医药导报，2018，24（13）：99-100.
[21] 刘冬博，王勋.扶正化痰固本方对早期非小细胞肺癌术后患者免疫功能的影响[J].河南中医，2020，40（5）：755-758.
[22] 刘彩凤，李思婷，王志国.基于数据挖掘探讨软坚散结法治疗声带小结的用药规律[J].中国医药导报，2021， 18（4）：119-122.
[23] Laccourreye O，Malinvaud D，Ménard M，et al. Unilateral laryngeal nerve paralysis in the adult：epidemiology，symptoms，physiopathology and treatment [J]. Presse Med，2014，43（4 Pt 1）：348-352.
[24] Bach ?譧，Sztanó B，Matievics V，et al. Isolated recovery of adductor muscle function following bilateral recurrent laryngeal nerve injuries [J]. Laryngoscope，2019，129（10）：2334-2340.
[25] 秦泠曦，孙易娜，吕文亮.吕文亮教授基于方证理论应用柴胡温胆汤经验撷华[J].世界中医药，2020，15（21）：3344-3347. |
|
|
|
